Mental Health: 5 Facts About Psychedelics

As mental health issues surge globally, especially following the COVID-19 pandemic, renewed interest in psychedelic drugs is driving research into their potential therapeutic uses. Psychedelics, which can be derived from natural sources like psilocybin mushrooms or synthesized in labs like LSD, are being explored for treating conditions such as depression, anxiety, PTSD, and addiction. Psychedelics may facilitate healing by inducing ego dissolution, allowing patients to gain new perspectives on their lives.
Historically, these substances were widely studied in the mid-20th century but faced research bans due to their association with counterculture. Today, while still classified as Schedule 1 drugs, psychedelics are being tested in controlled environments, offering hope for groundbreaking mental health treatments despite risks like psychosis and paranoia.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.